Company intelligence / Profile preview

Vytalyx

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Vytalyx is a health technology company specializing in AI-driven personalized medicine and longevity. The company leverages advanced data analytics and artificial intelligence to provide tailored health optimization protocols for individuals and healthcare providers. By integrating biomarkers, genetic data, and lifestyle factors, Vytalyx aims to extend human healthspan and prevent chronic diseases. Their platform serves as a bridge between complex health data and actionable clinical insights, focusing on preventative care and age management.

Therapeutic areas: OtherMetabolic Disorders
Modalities: Digital HealthArtificial Intelligence
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on Vytalyx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vytalyx.

Explore the full profile